500 Participants NeededMy employer runs this trial

Vonoprazan for Acid Reflux

PM
Overseen ByPhathom Medical Information
Age: 18+
Sex: Any
Trial Phase: Phase 3
Sponsor: Phathom Pharmaceuticals, Inc.
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The main objective is to assess the efficacy of vonoprazan (10 mg as needed) compared to placebo (as needed) in relief of episodic heartburn at 2 hours that is sustained for 24 hours over 12 weeks of treatment in participants with non-erosive gastroesophageal reflux disease (GERD).

Are You a Good Fit for This Trial?

This trial is for adults (18+) who have been diagnosed with non-erosive GERD and experience heartburn at least 4 days a week. Participants must be able to follow study instructions, keep an electronic diary, and women of childbearing age must use contraception.

Inclusion Criteria

I have had heartburn for at least 6 months.
My condition has been stable and I had no heartburn in the last 7 days.
I am 18 years old or older.
See 8 more

Exclusion Criteria

I have HIV, AIDS, hepatitis B, or active hepatitis C infection.
I am not pregnant, breastfeeding, or planning pregnancy or egg donation during the study.
I have had serious gastrointestinal bleeding in the past 4 weeks.
See 21 more

What Are the Treatments Tested in This Trial?

Trial Overview

The study compares vonoprazan (10 mg as needed) to a placebo in relieving episodic heartburn over up to 24 weeks. Participants are randomly assigned to either group and take the medication when they have symptoms.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Vonoprazan 10 mgExperimental Treatment1 Intervention
Group II: PlaceboPlacebo Group2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Phathom Pharmaceuticals, Inc.

Lead Sponsor

Trials
14
Recruited
4,400+